undefined undefined
NaN.000
NaN.00%
6 analysts have expressed a variety of opinions on Amicus Therapeutics (NASDAQ:...
05-15 03:00
Top Wall Street analysts changed their outlook on these top names. For a comple...
05-14 21:18
瑞银:维持Amicus Therapeutics(FOLD.US)评级,由买入调整至买入评级, 目标价由20.00美元调整至19.00美元。
05-11 02:21
B of A Securities analyst Tazeen Ahmad maintains Amicus Therapeutics (NASDAQ:FOLD) with a Buy and lowers the price target from $14 to $13.
05-10 19:42
Unity Software(U.US) reported fourth-quarter financial results after the market...
05-10 17:44
Needham analyst Gil Blum reiterates Amicus Therapeutics (NASDAQ:FOLD) with a Hold.
05-10 17:44
Needham analyst Gil Blum maintained a Hold rating on Amicus (FOLD – Research Re...
05-10 01:25
Amicus Therapeutics shares are trading lower following mixed Q1 earnings.
05-10 00:30
文|降噪NoNoise 如果说攀登者的终点是珠峰,钓鱼迷的终极梦想就是深海。 相比淡水和近海,深海区域的渔获种类更为稀缺、体型也更为庞大。从咬钩的那一刻开始...
05-09 11:21
Amicus Therapeutics (NASDAQ:FOLD) is scheduled to announce Q1 earnings results on Thursday, May 9th, before market open. The consensus EPS Estimate is -$0.03 and the consensus Revenue Estimate is $111...
05-09 02:18